T. Rowe Price Investment Management, Inc. Bio N Tech Se Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,598,472 shares of BNTX stock, worth $399 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,598,472
Previous 86,154
4076.79%
Holding current value
$399 Million
Previous $7.85 Million
4783.13%
% of portfolio
0.24%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
322Shares Held
41.1MCall Options Held
1.28MPut Options Held
1.43M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.51MShares$167 Million0.79% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...